RU2015144076A3 - - Google Patents

Download PDF

Info

Publication number
RU2015144076A3
RU2015144076A3 RU2015144076A RU2015144076A RU2015144076A3 RU 2015144076 A3 RU2015144076 A3 RU 2015144076A3 RU 2015144076 A RU2015144076 A RU 2015144076A RU 2015144076 A RU2015144076 A RU 2015144076A RU 2015144076 A3 RU2015144076 A3 RU 2015144076A3
Authority
RU
Russia
Application number
RU2015144076A
Other languages
Russian (ru)
Other versions
RU2015144076A (ru
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/023357 external-priority patent/WO2014150477A1/en
Publication of RU2015144076A publication Critical patent/RU2015144076A/ru
Publication of RU2015144076A3 publication Critical patent/RU2015144076A3/ru

Links

RU2015144076A 2013-03-15 2014-03-11 Композиции рекомбинантного фактора viii RU2015144076A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361799495P 2013-03-15 2013-03-15
US61/799,495 2013-03-15
US201361869191P 2013-08-23 2013-08-23
US61/869,191 2013-08-23
PCT/US2014/023357 WO2014150477A1 (en) 2013-03-15 2014-03-11 Recombinant factor viii formulations

Publications (2)

Publication Number Publication Date
RU2015144076A RU2015144076A (ru) 2017-04-24
RU2015144076A3 true RU2015144076A3 (cg-RX-API-DMAC10.html) 2018-02-22

Family

ID=51580768

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015144076A RU2015144076A (ru) 2013-03-15 2014-03-11 Композиции рекомбинантного фактора viii

Country Status (17)

Country Link
US (1) US20160030524A1 (cg-RX-API-DMAC10.html)
EP (1) EP2970430A4 (cg-RX-API-DMAC10.html)
JP (1) JP2016518321A (cg-RX-API-DMAC10.html)
KR (1) KR20150132449A (cg-RX-API-DMAC10.html)
CN (1) CN105209487A (cg-RX-API-DMAC10.html)
AU (1) AU2014237111B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015022730A2 (cg-RX-API-DMAC10.html)
CA (1) CA2905739A1 (cg-RX-API-DMAC10.html)
HK (1) HK1213273A1 (cg-RX-API-DMAC10.html)
MX (1) MX2015012905A (cg-RX-API-DMAC10.html)
PE (1) PE20160121A1 (cg-RX-API-DMAC10.html)
RU (1) RU2015144076A (cg-RX-API-DMAC10.html)
SG (2) SG10201803999UA (cg-RX-API-DMAC10.html)
TW (1) TW201521761A (cg-RX-API-DMAC10.html)
UY (1) UY35412A (cg-RX-API-DMAC10.html)
WO (1) WO2014150477A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201507684B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016115561A1 (en) * 2015-01-18 2016-07-21 Biogen Ma Inc. Formulations and screening of biological therapeutic agents
CN108884145B (zh) 2015-11-13 2023-08-22 武田药品工业株式会社 用于血友病a的基因治疗的具有增加的表达的编码重组fviii变体的病毒载体
US12091675B2 (en) 2018-07-16 2024-09-17 Takeda Pharmaceutical Company Limited Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression
TWI851647B (zh) 2019-01-16 2024-08-11 日商武田藥品工業股份有限公司 用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體
WO2021032646A1 (en) * 2019-08-16 2021-02-25 Octapharma Ag Stabilizing buffer for factor viii and vwf

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
CN1339170A (zh) * 1999-02-01 2002-03-06 日本电气硝子株式会社 阴极射线管及其制造方法
EP1820516B1 (en) * 1999-02-22 2013-07-24 University of Connecticut Novel albumin-free factor VIII formulations
EP1421539B1 (en) * 2001-06-14 2009-10-28 The Scripps Research Institute Stabilized factor viii with engineered disulfide bonds
GB0207092D0 (en) * 2002-03-26 2002-05-08 Sod Conseils Rech Applic Stable pharmaceutical composition containing factor VIII
DK2371856T3 (en) * 2004-11-12 2022-08-08 Bayer Healthcare Llc Site-directed modifikation af FVIII
WO2007126808A1 (en) * 2006-03-31 2007-11-08 Baxter International Inc Pegylated factor viii
EP2385825B1 (en) * 2008-11-07 2018-10-10 University of Connecticut Factor viii formulations
CA2748662A1 (en) * 2009-01-19 2010-07-22 Bayer Healthcare Llc Protein conjugate having an endopeptidase-cleavable bioprotective moiety

Similar Documents

Publication Publication Date Title
BR112021000792B8 (cg-RX-API-DMAC10.html)
AT524874A5 (cg-RX-API-DMAC10.html)
AT524834A2 (cg-RX-API-DMAC10.html)
AU2018438767B1 (cg-RX-API-DMAC10.html)
AT521543A3 (cg-RX-API-DMAC10.html)
AT524961A5 (cg-RX-API-DMAC10.html)
AT524266A2 (cg-RX-API-DMAC10.html)
BR102019026286B1 (pt) Método e aparelho para o avanço de produtos a serem moldados
BR102019025884B1 (pt) Sistema de segurança aprimorado para máquinas de operação de autopropulsão
BR102019023514B1 (pt) Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna
BR112020016338B1 (pt) Dispositivo para tratamento de tecido corporal
BR112021001374B1 (pt) Composição farmacêutica para o tratamento da hipertensão e seu uso
BR112021001128B1 (pt) Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit
BR112021001186B1 (pt) Aparelho para o tratamento de celulite para tratar expressões de celulite na pele de um paciente associadas a um local de tratamento de septos
BR112021000922B1 (pt) Tela de filtro, e, método para purificar água de alimentação
BR112020026077B1 (pt) Recipiente com estrutura encaixável
BR112020026721B1 (pt) Aparelho de moldagem para modar uma folha de um material contendo alcaloides
BR102019012845B1 (pt) Montagens de guia de entrada de piso de compartimento de carga retráteis para carregamentos paletizados em aeronaves de carga e aeronave e carga
BR112020023832B1 (pt) Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral
BR112020024987B1 (pt) Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico
BR112020023823B1 (pt) Distribuidor
BR112020022482B1 (pt) Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico
BR112020022658B1 (pt) Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido
BR112020022516B1 (pt) Processo para degomagem enzimática de óleo
BR112020021042B1 (pt) Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas